Analyst coverage and company performance data published regarding Jazz Pharmaceuticals, involving MarketBeat, Royal Bank of Canada, and TD Cowen.

The entities involved

• Jazz Pharmaceuticals →

  Irish tax-registered pharmaceutical corporation

  • Jazz Pharmaceuticals plans U.S. launch of Ziihera.Wed 22:28
  • Alan M. Sebulsky was appointed to the Board of Directors of MeiraGTx Holdings PLC, where he has previously served.Wed 13:55
• Royal Bank of Canada →

  financial institution in Canada

  • Royal Bank of Canada raised its holdings in the Dimensional US Sustainability Core 1 ETF on June 19, 2026.Mon 16:02
  • PrairieSky Royalty Ltd. operates in the Western Canadian Sedimentary Basin and is currently receiving research ratings from Royal Bank of Canada (RBC).Mon 09:02
• TD Cowen →

  American investment bank

  • Analyst downgraded Ag Growth International Inc. due to debt management risks.Mon 12:33
  • TD Cowen raised its price target and gave a buy rating for Travere Therapeutics, Inc., while various institutional investors bought into the company.Mon 10:36

Related events

• Analysts from Raymond James Financial, Desjardins, and Royal Bank of Canada increased price targets and ratings for Exchange Income Co.Tue 20:57
• Cohu, Inc. received analyst research and price targets from TD Cowen while trading on Nasdaq, with data aggregated by MarketBeat.Aug 19
• Analyst firm TD Cowen provided ratings and price targets for Moog, while MarketBeat aggregated consensus data. A pension fund also bought a new stake in the company.Sep 22
• Analyst reports are affecting price targets and ratings for Eldorado Gold, involving Royal Bank of Canada and Scotiabank.Jul 22
• MarketBeat reports average rating and target price for SS&C Technologies, while RBC boosts targets and Jefferies reduces its price objective.Sep 3